All filters
Slidesets
SARS-CoV-2 Antibody Seroprevalence in Previously Undiagnosed Persons in Tbilisi, Georgia: Results of Three Repeated Serosurveys - Akaki Abutidze
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV & COVID-19 Coinfection - Anca Streinu-Cercel, MD, PhD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Update on COVID-19 Therapeutics - Daniel Kuritzkes, MD
Dr. Kuritzkes, Daniel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
HIV Prevention in High Risk Populations: Unique Challenges and Solutions - Jean-Michel Molina, MD, PhD
Dr. Molina, Jean-Michel
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Long-Acting Therapy for PrEP: How Will We Use it? - Luis Mendão
Mr. Mendão, Luis
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Rollout of PrEP in Europe: Success Stories and Challenges - Teymur Noori, MSc
Dr. Noori, Teymur
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Update on the Use of Generic Drugs for HIV in Europe - Liudmyla Maistat
Ms. Maistat, Liudmyla
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
EASL Guidelines on Viral Hepatitis Elimination - Mojca Matičič, MD, PhD
Prof. Matičič, Mojca
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
The Georgian Model for Hepatitis C Elimination (With Reflection on the Impact of COVID-19 Pandemic) - Tengiz Tsertsvadze, MD, PHD
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
A Report on The Progress Towards Ending HIV - Nicole Seguy, MD, MPH
Presented at:
Central and Eastern European Meeting on Viral Hepatitis and HIV 2021
Slidesets
Laura Waters - Metabolic complications of Antiretroviral Therapy
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
Mas Chaponda - State of the Art – Clinical Pharmacology of Integrase Inhibitors
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
Ahmad Alharbi - Effective Transitioning to New Antiretroviral Regimens in Middle East Countries,
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
Hawra Albayat - National and international guidelines For HIV treatment UPDATED
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
Roger Paredes - State of the Art – Resistance to Integrase Inhibitors
Presented at:
GCC HIV Clinical Forum 2021
Slidesets
Intervening for HIV Prevention and Mental Health - Pamela Collins, MD, MPH
Presented at:
AIDSImpact 2021 | Webinar Series
Slidesets
Mental Health and HIV - François Venter, MD, FCP, PhD
Presented at:
AIDSImpact 2021 | Webinar Series
Slidesets
Scaleable Interventions for Mental Health - Dixon Chibanda
Presented at:
AIDSImpact 2021 | Webinar Series
Slidesets
Infection and Uncertainty The Challenges of Living With HIV and Caring for Patients and Families Affected by HIV - Richard Harding, PhD
Presented at:
AIDSImpact 2021 | Webinar Series
Slidesets
RTI 2021 - Laura Waters - Clinical Review: New RT Inhibitors – Doravirine
Presented at:
Leveraging Reverse Transcriptase in HIV 2021
Slidesets
Revisiting Post COVID-19 Syndrome - Z. Al-Aly, MD, FASN
Presented at:
COVID-19 Clinical Forum 2021
Slidesets
Update on COVID-19 Therapeutics (October Edition) - D.Kuritzkes, MD
Presented at:
COVID-19 Clinical Forum 2021
Slidesets
RTI 2021 - Graeme J. Moyle - Remaining Gaps in Current HIV Therapy
Presented at:
Leveraging Reverse Transcriptase in HIV 2021
Slidesets
RTI 2021 - François Venter - Clinical Review: New RT Inhibitors – Islatravir
Presented at:
Leveraging Reverse Transcriptase in HIV 2021